Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • chimakot chimakot Feb 14, 2013 6:10 PM Flag

    Very good seeking alpha article released after the bell.

    It's an interview with a noted expert in this sector. Read it, it's worth the time.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • TLSR: Could we talk about some companies? Go ahead with an idea.

      RS: At this juncture, we are looking primarily at companies with significant value-driving catalysts this year. One of these is antibiotic developer Trius Therapeutics Inc. (TSRX). We have been bullish on Trius for quite some time. It recently raised capital; it is very well-funded. It is highly unlikely that there will be an additional near-term dilutive capital raise. We think investors should take a look at this company now, and consider this a reasonable and timely entry point.

      TLSR: Go ahead and talk about the catalyst. When is it anticipated?

      RS: It is expected to occur in the second half of March, with the release of top-line data from a second phase 3 trial of the company's novel antibiotic, tedizolid phosphate, a member of the oxazolidinone family. This is a confirmatory trial for skin structure infections. Since the designs of the first phase 3 trial and this one are virtually identical, we believe the second trial will be positive as well. We are very enthusiastic about the upcoming data release.

 
TSRX
13.630.0000(0.00%)Sep 11 4:00 PMEDT